Teva Pharm. USA, Inc. v. Superior Court of Cal.
138 S. Ct. 88, 199 L. Ed. 2d 27, 86 U.S.L.W. 3149, 2017 WL 2021658, 2017 U.S. LEXIS 5328
This text of 138 S. Ct. 88 (Teva Pharm. USA, Inc. v. Superior Court of Cal.) is published on Counsel Stack Legal Research, covering Supreme Court of the United States primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Bluebook
Teva Pharm. USA, Inc. v. Superior Court of Cal., 138 S. Ct. 88, 199 L. Ed. 2d 27, 86 U.S.L.W. 3149, 2017 WL 2021658, 2017 U.S. LEXIS 5328 (U.S. 2017).
Opinion
Petition for writ of certiorari to the Court of Appeal of California, First Appellate District denied.
Free access — add to your briefcase to read the full text and ask questions with AI
Cite This Page — Counsel Stack
Bluebook (online)
138 S. Ct. 88, 199 L. Ed. 2d 27, 86 U.S.L.W. 3149, 2017 WL 2021658, 2017 U.S. LEXIS 5328, Counsel Stack Legal Research, https://law.counselstack.com/opinion/teva-pharm-usa-inc-v-superior-court-of-cal-scotus-2017.